295 related articles for article (PubMed ID: 29982575)
1. Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques.
Russo AT; Grosenbach DW; Brasel TL; Baker RO; Cawthon AG; Reynolds E; Bailey T; Kuehl PJ; Sugita V; Agans K; Hruby DE
J Infect Dis; 2018 Sep; 218(9):1490-1499. PubMed ID: 29982575
[TBL] [Abstract][Full Text] [Related]
2. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D
Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948
[TBL] [Abstract][Full Text] [Related]
3. Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection.
Berhanu A; Prigge JT; Silvera PM; Honeychurch KM; Hruby DE; Grosenbach DW
Antimicrob Agents Chemother; 2015 Jul; 59(7):4296-300. PubMed ID: 25896687
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model.
Hutson CL; Kondas AV; Mauldin MR; Doty JB; Grossi IM; Morgan CN; Ostergaard SD; Hughes CM; Nakazawa Y; Kling C; Martin BE; Ellison JA; Carroll DS; Gallardo-Romero NF; Olson VA
mSphere; 2021 Feb; 6(1):. PubMed ID: 33536322
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and pharmacodynamic modeling to determine the dose of ST-246 to protect against smallpox in humans.
Leeds JM; Fenneteau F; Gosselin NH; Mouksassi MS; Kassir N; Marier JF; Chen Y; Grosenbach D; Frimm AE; Honeychurch KM; Chinsangaram J; Tyavanagimatt SR; Hruby DE; Jordan R
Antimicrob Agents Chemother; 2013 Mar; 57(3):1136-43. PubMed ID: 23254433
[TBL] [Abstract][Full Text] [Related]
6. ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification.
Jordan R; Goff A; Frimm A; Corrado ML; Hensley LE; Byrd CM; Mucker E; Shamblin J; Bolken TC; Wlazlowski C; Johnson W; Chapman J; Twenhafel N; Tyavanagimatt S; Amantana A; Chinsangaram J; Hruby DE; Huggins J
Antimicrob Agents Chemother; 2009 May; 53(5):1817-22. PubMed ID: 19223621
[TBL] [Abstract][Full Text] [Related]
7. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection.
Stittelaar KJ; Neyts J; Naesens L; van Amerongen G; van Lavieren RF; Holý A; De Clercq E; Niesters HG; Fries E; Maas C; Mulder PG; van der Zeijst BA; Osterhaus AD
Nature; 2006 Feb; 439(7077):745-8. PubMed ID: 16341204
[TBL] [Abstract][Full Text] [Related]
8. A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus.
Stabenow J; Buller RM; Schriewer J; West C; Sagartz JE; Parker S
J Virol; 2010 Apr; 84(8):3909-20. PubMed ID: 20130052
[TBL] [Abstract][Full Text] [Related]
9. Oral Tecovirimat for the Treatment of Smallpox.
Grosenbach DW; Honeychurch K; Rose EA; Chinsangaram J; Frimm A; Maiti B; Lovejoy C; Meara I; Long P; Hruby DE
N Engl J Med; 2018 Jul; 379(1):44-53. PubMed ID: 29972742
[TBL] [Abstract][Full Text] [Related]
10. New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus.
DeLaurentis CE; Kiser J; Zucker J
Antimicrob Agents Chemother; 2022 Dec; 66(12):e0122622. PubMed ID: 36374026
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (Smallpox).
Mucker EM; Goff AJ; Shamblin JD; Grosenbach DW; Damon IK; Mehal JM; Holman RC; Carroll D; Gallardo N; Olson VA; Clemmons CJ; Hudson P; Hruby DE
Antimicrob Agents Chemother; 2013 Dec; 57(12):6246-53. PubMed ID: 24100494
[TBL] [Abstract][Full Text] [Related]
12. Experimental infection of cynomolgus macaques (Macaca fascicularis) with aerosolized monkeypox virus.
Nalca A; Livingston VA; Garza NL; Zumbrun EE; Frick OM; Chapman JL; Hartings JM
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862223
[TBL] [Abstract][Full Text] [Related]
13. Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246.
Huggins J; Goff A; Hensley L; Mucker E; Shamblin J; Wlazlowski C; Johnson W; Chapman J; Larsen T; Twenhafel N; Karem K; Damon IK; Byrd CM; Bolken TC; Jordan R; Hruby D
Antimicrob Agents Chemother; 2009 Jun; 53(6):2620-5. PubMed ID: 19349521
[TBL] [Abstract][Full Text] [Related]
14. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review.
Shamim MA; Padhi BK; Satapathy P; Veeramachaneni SD; Chatterjee C; Tripathy S; Akhtar N; Pradhan A; Dwivedi P; Mohanty A; Rodriguez-Morales AJ; Sah R; Al-Tammemi AB; Al-Tawfiq JA; Nowrouzi-Kia B; Chattu VK
Int J Infect Dis; 2023 Feb; 127():150-161. PubMed ID: 36470502
[TBL] [Abstract][Full Text] [Related]
15. Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: A study protocol for an Expanded Access Programme.
Bourner J; Redji Mbrenga FD; Malaka CN; Dunning J; Rojek A; Fandema E; Horby P; Boum Y; Nakouné E; Olliaro P
PLoS One; 2024; 19(5):e0278957. PubMed ID: 38722986
[TBL] [Abstract][Full Text] [Related]
16. Can a smallpox drug treat monkeypox? Compassionate use of tecovirimat for monkeypox infection.
Fatima M; Ahmed A; Murad MW; Afzal Z
Eur J Intern Med; 2023 Jan; 107():105-106. PubMed ID: 36153182
[No Abstract] [Full Text] [Related]
17. Sequence of pathogenic events in cynomolgus macaques infected with aerosolized monkeypox virus.
Tree JA; Hall G; Pearson G; Rayner E; Graham VA; Steeds K; Bewley KR; Hatch GJ; Dennis M; Taylor I; Roberts AD; Funnell SG; Vipond J
J Virol; 2015 Apr; 89(8):4335-44. PubMed ID: 25653439
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo efficacy of tecovirimat against a recently emerged 2022 monkeypox virus isolate.
Warner BM; Klassen L; Sloan A; Deschambault Y; Soule G; Banadyga L; Cao J; Strong JE; Kobasa D; Safronetz D
Sci Transl Med; 2022 Nov; 14(673):eade7646. PubMed ID: 36318038
[TBL] [Abstract][Full Text] [Related]
19. Tecovirimat, a p37 envelope protein inhibitor for the treatment of smallpox infection.
Duraffour S; Andrei G; Snoeck R
IDrugs; 2010 Mar; 13(3):181-91. PubMed ID: 20191435
[TBL] [Abstract][Full Text] [Related]
20. Infection of cynomolgus macaques with a recombinant monkeypox virus encoding green fluorescent protein.
Goff A; Mucker E; Raymond J; Fisher R; Bray M; Hensley L; Paragas J
Arch Virol; 2011 Oct; 156(10):1877-81. PubMed ID: 21814864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
